Contract facts
UnrestrictedNo full NAICS 325413 intel page yet. Browse NAICS intelligence
Pursuant to Federal Acquisition Regulation (FAR) 52.217-9, Option to Extend the Term of the Contract, W81K00-22-P-0269… is a federal Unrestricted award for W40m Mrc0 West held by Diasorin Molecular LLC. Estimated value $140K ($26K obligated). Current period of performance ends Sep 30, 2027. Last award drew 1 bidder. Place of performance: JBSA FT SAM HOUSTON TX. Related solicitation W81K0022Q0165.
Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, w81k00-22-p-0269 with diasorin molecular, llc. is hereby extended for the period 01 october 2026 - 30 september 2027 (option period 4). Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Sep 30, 2027 (344 days remaining). Agencies typically plan 12–18 months ahead — at 11.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on W81K0022P0269? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordDiasorin Molecular LLC — $16.5M obligated across 436 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0022P0269?
W81K0022P0269 (FAR pursuant federal acquisition regulation) is a W40m Mrc0 West award with a potential value of $140K, currently held by Diasorin Molecular LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81K00-22-P-0269?
W81K00-22-P-0269 is the dashed form of PIID W81K0022P0269 (FAR pursuant federal acquisition regulation), held by Diasorin Molecular LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81K0022P0269?
W40m Mrc0 West awarded W81K0022P0269 to Diasorin Molecular LLC (potential $140K).
Who is the incumbent on W81K0022P0269?
Diasorin Molecular LLC is the incumbent with $16.5M across 436 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.
When does Diasorin Molecular LLC’s W81K0022P0269 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W81K0022P0269? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.